CN101940661A - Medicament for treating hyperosteogeny - Google Patents
Medicament for treating hyperosteogeny Download PDFInfo
- Publication number
- CN101940661A CN101940661A CN2010102867658A CN201010286765A CN101940661A CN 101940661 A CN101940661 A CN 101940661A CN 2010102867658 A CN2010102867658 A CN 2010102867658A CN 201010286765 A CN201010286765 A CN 201010286765A CN 101940661 A CN101940661 A CN 101940661A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicament
- medicine
- hyperosteogeny
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a medicament for treating hyperosteogeny. The medicament is a capsule product prepared by mixing garter snake, spina gleditsiae, pangolin, garden balsam stem, trogopterus dung, asarum, kadsura pepper stem, heracleum hemsleyanum michaux, herba epimedii, Chinese clematis, lycopodium clavatum, root of rehmannia, liquorice, achyranthes, centipede, codonopsis pilosula, white paeony root, root of red-rooted salvia, scorpio and rhizoma cibotii, crushing the mixture into 100 to 120-mesh medicinal powder, filling the powder into capsules and sterilizing the capsules. The medicament has the effects of expelling wind from bones, warming meridians and dredging collaterals, expelling wind and dehumidifying, activating blood and dissolving stasis, expelling cold evil to kill pain and nourishing liver and kidney, can be used for treating hyperosteogeny and has the characteristics of clear, quick and convenient treatment effect, low price and safe administration. Clinical observation shows that the curative ratio of the medicament is 94.5 percent.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of hyperosteogeny, particularly relating to a kind of is the Chinese medicine of the treatment hyperosteogeny of feedstock production with Chinese medicine.
Background technology
Hyperosteogeny medically is being called osteoarthritis or osteoarthritis, mainly is because due to the bone wearing and tearing that the mechanical stress distribution is unbalance or load excessively causes.Every day is all being born the mechanical force that comings and goings causes in people's joint, and after people in middle age, muscle function is faded, and causes joint injury easily, and cartilage destruction causes osteoarthritis.Hyperosteogeny is middle old man's a common frdquently encountered disease, is mainly in the mobility maximum, the positions such as maximum cervical vertebras, lumbar vertebra, sacral, knee joint, heel of bearing a heavy burden.With advancing age, people's articular cartilage elasticity can fall sharply, and the chondrigen fiber appears, and very easily weares and teares when the middle part, joint is movable, and its periphery cartilage surface just metabolic increases the plumpness of dying, the ossified at last bony spur that forms.
The method of treatment hyperosteogeny mainly contains operative treatment, physical therapy, Western medicine and treatment by Chinese herbs etc. at present.But, adopt operation method expense height, and increase patient's misery; Though adopt physical therapy method can alleviate patient's misery, just, can not effect a radical cure to the alleviation of symptom; Adopt western medicine, its drug price is more expensive, and may cause side effect; At present the treatment by Chinese herbs method that adopts takes effect slowly, and the state of an illness recurs easily, and Chinese prescription and preparation method thereof complexity, and the drug cost height is difficult to be accepted by the patient.
Summary of the invention
The purpose of this invention is to provide a kind of medicine that is used for the treatment of hyperosteogeny, deep wind, promoting the flow of QI in the collateral by warming the meridian, expelling wind and dampness, blood circulation promoting and blood stasis dispelling, the pain relieving cold expelling searched of this medicine, nourishing the liver and kidney, to rheumatic arthritis, the arthralgic treatment of hyperosteogeny can be played treating both the principal and secondary aspects of a disease, drug effect is rapid, the purpose that therapeutic effect is good.
Medicine of the present invention is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Zaocys 12~16 Spina Gleditsiae 8~12
Squama Manis 3~6 Herba speranskiae tuberculataes 10~15
Oletum Trogopterori 8~12 Herba Asaris 3~6
Caulis Piperis Kadsurae 12~16 Radix Angelicae Pubescentiss 8~12
Herba Epimedii 3~6 Radix Clematidis 8~12
Herba Lycopodii 3~6 Radix Rehmanniae 12~16
Radix Glycyrrhizae 8~12 Radix Achyranthis Bidentataes 12~16
Scolopendra 2~5 Radix Codonopsis 12~16
The Radix Paeoniae Alba 12~16 Radix Salviae Miltiorrhizaes 15~25
Scorpio 12~16 Rhizoma Cibotii 12~16.
Said medicine can be made any dosage form on the pharmaceutics, as tablet, pill, powder, capsule etc., the preferred dosage form of the present invention is a capsule.
The concrete preparation method of medicine of the present invention being made capsule is:
Said medicine by described parts by weight mix homogeneously, is ground into 100~120 purpose medicated powder, and in incapsulating, sterilization makes the capsule product.
Bone matrix hyperplasia belongs to the traditional Chinese medical science " arthromyodynia " category, and the cause of disease is the natural endowment deficiency, and the day after tomorrow, impairment caused by overstrain of a specified duration and Liver and kidney caused deficiency of liver-blood, and the muscle arteries and veins loses supports; Deficiency of kidney-essence, bone is become homeless foster; Muscle loses and makes moist, and venation block is inaccessible obstructed.The Therapeutic Principle is deep wind, promoting the flow of QI in the collateral by warming the meridian, expelling wind and dampness, blood circulation promoting and blood stasis dispelling, the pain relieving cold expelling searched, nourishing the liver and kidney.Zaocys wind-damp dispelling, the meridian dredging; Spina Gleditsiae draw out pus by applying a plaster to the affected part evacuation of pus, promoting blood circulation and detumescence; The promoting the circulation of blood of Squama Manis parasite killing, the dissipating blood stasis of assaulting fortified position; The Oletum Trogopterori promoting blood circulation to remove blood stasis; Herba Asari expelling wind and cold, Hang Shui have one's ideas straightened out; Caulis Piperis Kadsurae wind-damp dispelling, the meridian dredging, stopping numbness pain; The detoxifcation of Radix Angelicae Pubescentis dispelling wind, promoting blood circulation to disperse blood clots and relieves pain; Herba Epimedii kidney-replenishing, bone and muscle strengthening, wind-damp dispelling; Radix Clematidis, Herba Lycopodii expelling wind and removing dampness, removing obstruction in the collateral to relieve pain; Radix Rehmanniae clearing away heat and cooling blood; Radix Glycyrrhizae invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription; Radix Achyranthis Bidentatae eliminating blood stasis and inducing menstruation, easing joint movement, inducing diuresis for treating stranguria syndrome; Scolopendra, Scorpio endogenous wind stopping spasmolytic, merit poison eliminating stagnation, removing obstruction in the collateral to relieve pain; Radix Codonopsis invigorating the spleen and replenishing QI, spleen invigorating lung benefiting; Radix Paeoniae Alba nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing are received antiperspirant; Radix Salviae Miltiorrhizae promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Rhizoma Cibotii wind-damp dispelling, invigorating the liver and kidney, strong waist knee joint.All medicines share, deep wind, promoting the flow of QI in the collateral by warming the meridian, expelling wind and dampness, blood circulation promoting and blood stasis dispelling, pain relieving cold expelling, the nourishing the liver and kidney searched, be used for rheumatic arthritis, the treatment of cold-damp arthralgia, hyperosteogeny etc. has curative effect really, rapidly, conveniently, the medicine valency is cheap, takes safe characteristics.
For further investigating the clinical efficacy and the safety of medicine of the present invention, select 36 routine hyperosteogeny patients that the curative effect of medicine of the present invention has been carried out clinical observation.
36 routine cases are divided into two groups at random, every group 18 example.All case all is diagnosed as hyperosteogeny according to diagnosis basis and typing in " hyperosteogeny diagnosis and treatment complete works ".
Therapeutic Method
Matched group adopts with Novolten capsule (Hainan Pulin Pharmaceutical Co., Ltd's production), takes each 3 every day 2 times.The treatment group adopts medicine of the present invention to treat, and takes each 6 every day 2 times.7 days is a course of treatment, takes 3 courses of treatment altogether.
Criterion of therapeutical effect
Formulate with reference to State Administration of Traditional Chinese Medicine's " traditional Chinese medical science disease diagnosis criterion of therapeutical effect ".Recovery from illness: pain symptom disappears, and activity is followed up a case by regular visits to not recurrence in 1 year freely.Effectively: pain symptom alleviates, and still has sense of discomfort, follows up a case by regular visits to and does not increase the weight of in 1 year.Invalid: pain symptom and the preceding contrast of treatment no change.
Two groups of case treatment back curative effect comparative results see Table 1.
Table 1 liang group case treatment back curative effect relatively
The specific embodiment
Embodiment 1
Get Zaocys 75g selected, that clear water is cleaned, Spina Gleditsiae 50g, Squama Manis 25g, Herba speranskiae tuberculatae 60g, Oletum Trogopterori 50g, Herba Asari 25g, Caulis Piperis Kadsurae 75g, Radix Angelicae Pubescentis 50g, Herba Epimedii 25g, Radix Clematidis 50g, Herba Lycopodii 25g, Radix Rehmanniae 75g, Radix Glycyrrhizae 50g, Radix Achyranthis Bidentatae 75g, Scolopendra 20g, Radix Codonopsis 75g, Radix Paeoniae Alba 75g, Radix Salviae Miltiorrhizae 100g, Scorpio 75g, Rhizoma Cibotii 75g mix homogeneously, be ground into 120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.
Embodiment 2
Get Zaocys 120g selected, that clear water is cleaned, Spina Gleditsiae 120g, Squama Manis 40g, Herba speranskiae tuberculatae 150g, Oletum Trogopterori 80g, Herba Asari 40g, Caulis Piperis Kadsurae 160g, Radix Angelicae Pubescentis 120g, Herba Epimedii 80g, Radix Clematidis 100g, Herba Lycopodii 60g, Radix Rehmanniae 120g, Radix Glycyrrhizae 80g, Radix Achyranthis Bidentatae 160g, Scolopendra 40g, Radix Codonopsis 150g, Radix Paeoniae Alba 150g, Radix Salviae Miltiorrhizae 240g, Scorpio 120g, Rhizoma Cibotii 150g mix homogeneously, be ground into 100 purpose medicated powder, in incapsulating, sterilization makes the capsule product.
Claims (2)
1. medicine that is used for the treatment of hyperosteogeny is that feedstock production obtains by the Chinese medicine of following portions by weight:
Zaocys 12~16 Spina Gleditsiae 8~12
Squama Manis 3~6 Herba speranskiae tuberculataes 10~15
Oletum Trogopterori 8~12 Herba Asaris 3~6
Caulis Piperis Kadsurae 12~16 Radix Angelicae Pubescentiss 8~12
Herba Epimedii 3~6 Radix Clematidis 8~12
Herba Lycopodii 3~6 Radix Rehmanniae 12~16
Radix Glycyrrhizae 8~12 Radix Achyranthis Bidentataes 12~16
Scolopendra 2~5 Radix Codonopsis 12~16
The Radix Paeoniae Alba 12~16 Radix Salviae Miltiorrhizaes 15~25
Scorpio 12~16 Rhizoma Cibotii 12~16.
2. the medicine that is used for the treatment of hyperosteogeny according to claim 1 is characterized in that described medicine is made capsule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102867658A CN101940661A (en) | 2010-09-16 | 2010-09-16 | Medicament for treating hyperosteogeny |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010102867658A CN101940661A (en) | 2010-09-16 | 2010-09-16 | Medicament for treating hyperosteogeny |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101940661A true CN101940661A (en) | 2011-01-12 |
Family
ID=43432991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010102867658A Pending CN101940661A (en) | 2010-09-16 | 2010-09-16 | Medicament for treating hyperosteogeny |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101940661A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101940656A (en) * | 2010-08-13 | 2011-01-12 | 山西省屯留县科技情报服务中心 | Medicament for treating hyperosteogeny |
-
2010
- 2010-09-16 CN CN2010102867658A patent/CN101940661A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101940656A (en) * | 2010-08-13 | 2011-01-12 | 山西省屯留县科技情报服务中心 | Medicament for treating hyperosteogeny |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103055278B (en) | Medicament for treating rheumatism | |
CN103463241A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation | |
CN102626505B (en) | Massaging paste based on Chinese medicinal herbs and preparation method thereof | |
CN101721651B (en) | Traditional Chinese medicine capsule for treating scapulohumeral periarthritis | |
CN102961483A (en) | Traditional Chinese medicine composition for treating pain in waist and lower extremities and preparation method thereof | |
CN103316296B (en) | Traditional Chinese medicine composition for treating hyperostosis | |
CN104922363A (en) | Traditional Chinese medicine composite for treating osteoproliferation | |
CN104306606A (en) | A traditional Chinese medicine preparation for treating osteoarthritis and a preparing method thereof | |
CN104107288A (en) | Sinew-relaxing collateral-activating pill | |
CN102579672A (en) | Medicament for treating bone hyperplasia and lumbar disc herniation | |
CN102370688A (en) | Compound Chinese medicinal preparation for treating hyperosteogeny and preparation method thereof | |
CN102406870A (en) | Medicament for treating rheumatic arthralgia | |
CN105412692A (en) | Traditional Chinese medicine preparation for treating arthroncus of knees | |
CN101284087B (en) | Medicinal composition for curing lumbar disease | |
CN101940656A (en) | Medicament for treating hyperosteogeny | |
CN104873615A (en) | Cinnamon oil containing externally applied medicine for treating traumatic injury | |
CN104644928A (en) | Medicine for treating cervical and lumbar disc herniations | |
CN104721427A (en) | Traditional Chinese medicine preparation for treating rheumatic bone diseases | |
CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
CN101637535B (en) | Medicine for treating bone hyperplasia and preparation method thereof | |
CN102614350A (en) | Chinese medicine for treating cervical spondylosis | |
CN102028810B (en) | Traditional Chinese medicine for treating lumbar intervertebral disc protrusion | |
CN115645503B (en) | Medicinal composition and acupoint application paste for treating chronic pain diseases | |
CN102512543A (en) | Chinese medicinal composition for treating rheumatoid arthritis | |
CN101940661A (en) | Medicament for treating hyperosteogeny |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20110112 |